Immunosuppressive treatment protects against angiotensin II-induced renal damage
about
Recent advances in central cardiovascular control: sex, ROS, gas and inflammationDendritic Cells and Their Role in Cardiovascular Diseases: A View on Human StudiesInfiltrating immune cells in the kidney in salt-sensitive hypertension and renal injuryInflammation, immunity, and hypertensive end-organ damageAngiotensin II in inflammation, immunity and rheumatoid arthritisAn update on immune system activation in the pathogenesis of hypertensionThe inextricable role of the kidney in hypertensionDetermination of an angiotensin II-regulated proteome in primary human kidney cells by stable isotope labeling of amino acids in cell culture (SILAC)Soluble epoxide hydrolase gene deletion attenuates renal injury and inflammation with DOCA-salt hypertensionTumor necrosis factor-α produced in the kidney contributes to angiotensin II-dependent hypertension.Endothelial dysfunction and the development of renal injury in spontaneously hypertensive rats fed a high-fat dietAggravated renal inflammatory responses in TRPV1 gene knockout mice subjected to DOCA-salt hypertension.TNF-alpha inhibition reduces renal injury in DOCA-salt hypertensive rats.Soluble TNF receptors and kidney dysfunction in the elderly.Molecular mechanisms of chronic kidney transplant rejection via large-scale proteogenomic analysis of tissue biopsies.T lymphocytes mediate hypertension and kidney damage in Dahl salt-sensitive rats.Classical Renin-Angiotensin system in kidney physiologyRecent advances involving the renin-angiotensin systemTNFR1-deficient mice display altered blood pressure and renal responses to ANG II infusion.Tumor necrosis factor-alpha antagonist etanercept decreases blood pressure and protects the kidney in a mouse model of systemic lupus erythematosusEpoxide hydrolase and epoxygenase metabolites as therapeutic targets for renal diseases.The anti-fibrotic effect of mycophenolic acid-induced neutral endopeptidase.Inflammation, immunity, and hypertension.An orally active epoxide hydrolase inhibitor lowers blood pressure and provides renal protection in salt-sensitive hypertensionThe immunological basis of hypertensionHigh dietary protein exacerbates hypertension and renal damage in Dahl SS rats by increasing infiltrating immune cells in the kidney.Infiltrating T lymphocytes in the kidney increase oxidative stress and participate in the development of hypertension and renal diseaseInhibition of TNF in the brain reverses alterations in RAS components and attenuates angiotensin II-induced hypertensionImmunoglobulin locus associates with serum IgG levels and albuminuria.Autoimmunity: an underlying factor in the pathogenesis of hypertension.Relaxin does not improve Angiotensin II-induced target-organ damage.Role of T lymphocytes in hypertension.Central role of IL-17/Th17 immune responses and the gut microbiota in the pathogenesis of intestinal fibrosisRole of T lymphocytes in angiotensin II-mediated microvascular thrombosisLymphocyte responses exacerbate angiotensin II-dependent hypertension.Oxidative stress, renal infiltration of immune cells, and salt-sensitive hypertension: all for one and one for all.Statin, calcium channel blocker and Beta blocker therapy may decrease the incidence of tuberculosis infection in elderly Taiwanese patients with type 2 diabetesAngiotensin II induces connective tissue growth factor gene expression via calcineurin-dependent pathways.Eicosanoids and tumor necrosis factor-alpha in the kidney.Protective effect of TRPV1 against renal fibrosis via inhibition of TGF-β/Smad signaling in DOCA-salt hypertension.
P2860
Q26752442-B11049A5-4842-4493-9B49-7B079DBD7094Q26752811-AC131C29-9596-49AD-8A56-81B06115A746Q26822514-22FDBE75-0333-4221-ACA4-7EE1907AF80BQ26827525-7F71B048-848D-4271-A9A9-0DCF3D3A03B5Q26991828-A277693D-AC1D-4006-8660-578C087C0F77Q27013715-5A1E0AC4-1FDC-4180-9614-4EC00D9FB2B1Q28241252-07B26D97-3BE7-4BB1-9AAF-06ABDF4F0122Q28387627-7C70D407-1300-4FC0-925C-720ED3B86E36Q28390972-43AEE488-2B2A-4CD0-9192-D9D0193A9580Q30365965-5762DEDF-5DCD-451E-A8FA-444983952BD2Q30482887-B3C1C63E-5E59-4FB9-B0AF-6EF1B80CA093Q33570102-916D8227-B80C-42D0-BF73-7D0253795F4AQ33647618-1074ED4F-D94C-48A5-A5D8-916A48D504DBQ33660677-BDC405B5-9AF9-4920-BBA9-0206455B9FD6Q33711255-F25DB57E-E396-469B-BEBE-942E1ADD4CB1Q33784344-E16C8FE8-4F78-426C-BEC6-65E501696565Q34065655-904D8994-D7E8-47E7-BA2D-A3DF67C6AA53Q34260674-A9B240F2-CACE-41E8-942B-3186B2C03ABDQ34305595-FD8F755C-BA4A-4CCA-A33C-0DF0A1A6757EQ34339359-AE91AE89-4DB4-4228-AB48-BC70D22AC87CQ34442004-151CCE91-D525-418A-8E67-0BD4F718433FQ34457205-97023C69-0B43-4C7A-8752-090701D79EFDQ34528283-EE6267C2-BF23-4BB3-BD48-61920D1C8767Q34557130-F61CAE2B-83C1-47A6-9270-EE2467D1E514Q34683745-989535A6-C06C-4E9F-ADED-04F2525C2AAEQ34692169-EB0CFEF9-3A80-4E63-A58F-8D8935C56EBEQ34719254-B706ADEC-C20F-4FFF-BCD3-85569BD6FE41Q34731058-A7F8BEA1-756E-45F6-8F9A-F2BD1D7A0290Q34870753-F31E383C-BCBA-4DFF-A34A-3200334DB740Q35116086-40B17708-3B97-4029-887C-80F8D24F7862Q35141812-B746E939-CD52-4479-AD85-64E4DD49BE3EQ35236265-A9F7B209-AF31-4CF5-A30A-AF69F83514D7Q35276739-19AD7175-44FD-4CD1-A515-8D4A6FE1B4C8Q35421048-0B59B76B-A583-4318-83F0-B742373D573AQ35576468-60491063-D4D1-459A-904A-4B1A755E5495Q35682855-D8B8D414-9969-466C-B651-1B5BFCA0FC6AQ35723779-82D56954-0ED4-4654-B5E2-18A2F5EBEDBDQ35791591-BF5F640B-C9CC-44F9-8F3B-F258B0BE3C47Q35803739-7DD175B3-09C6-4504-8F4C-3E2D0DA06C7FQ35876750-F7D69F11-FA42-49C5-8CFC-22446DB7D912
P2860
Immunosuppressive treatment protects against angiotensin II-induced renal damage
description
2002 nî lūn-bûn
@nan
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
2002年论文
@zh
2002年论文
@zh-cn
name
Immunosuppressive treatment protects against angiotensin II-induced renal damage
@ast
Immunosuppressive treatment protects against angiotensin II-induced renal damage
@en
type
label
Immunosuppressive treatment protects against angiotensin II-induced renal damage
@ast
Immunosuppressive treatment protects against angiotensin II-induced renal damage
@en
prefLabel
Immunosuppressive treatment protects against angiotensin II-induced renal damage
@ast
Immunosuppressive treatment protects against angiotensin II-induced renal damage
@en
P2093
P2860
P50
P1476
Immunosuppressive treatment protects against angiotensin II-induced renal damage
@en
P2093
Christiane Viedt
Eero Mervaala
Franziska Hampich
Harald Heidecke
Joerg Kreuzer
Joon-Keun Park
Jürgen Theuer
Martin Zenke
Piet Finckenberg
Xinsheng Ju
P2860
P304
P356
10.1016/S0002-9440(10)64445-8
P407
P50
P577
2002-11-01T00:00:00Z